Next Article in Journal
Treatment with Remdesivir of Children with SARS-CoV-2 Infection: Experience from a Clinical Hospital in Romania
Previous Article in Journal
Extracellular Vesicles as Next-Generation Biomarkers in Lung Cancer Patients: A Case Report on Adenocarcinoma and Squamous Cell Carcinoma
 
 

Order Article Reprints

Journal: Life, 2024
Volume: 14
Number: 409

Article: Biodistribution Assessment of a Novel 68Ga-Labeled Radiopharmaceutical in a Cancer Overexpressing CCK2R Mouse Model: Conventional and Radiomics Methods for Analysis
Authors: by Anna Maria Pavone, Viviana Benfante, Paolo Giaccone, Alessandro Stefano, Filippo Torrisi, Vincenzo Russo, Davide Serafini, Selene Richiusa, Marco Pometti, Fabrizio Scopelliti, Massimo Ippolito, Antonino Giulio Giannone, Daniela Cabibi, Mattia Asti, Elisa Vettorato, Luca Morselli, Mario Merone, Marcello Lunardon, Alberto Andrighetto, Antonino Tuttolomondo, Francesco Paolo Cammarata, Marco Verona, Giovanni Marzaro, Francesca Mastrotto, Rosalba Parenti, Giorgio Russo and Albert Comelliadd Show full author list remove Hide full author list
Link: https://www.mdpi.com/2075-1729/14/3/409

MDPI provides article reprints in high quality with convenient shipping to destinations worldwide. The articles are printed in on premium paper with high-resolution figures. Our covers are customized to your article and designed to be complimentary to the journal. These reprints are ideal additions to your portfolio. Copy details: 135g/m2 paper, 2x stitched, full colour and glossy finish, orderable in quantities from 10 to 1000.

If you have any questions, or special requests, please write to our support team; we are happy to provide you with the information you need.

Reprint Options

If you need more than 400 copies, please contact us by e-mail (publisher@mdpi.com) and we will prepare an individual offer for you.

Order Cost and Details

Contact Person

Invoice Address

Notes or Comments

Validate and Place Order

The order must be prepaid after it is placed

req denotes required fields.
Back to TopTop